Fundamental dimension Equity attribute | LUNGLeader $1.83▼-2.66% Cap $78.60MP/E -1.6x QuantScore42/100 | ACRVPeer $1.73▼-1.70% Cap $74.14MP/E -0.9x QuantScore39/100 | ASRTPeer $23.500.00% Cap $151.9MP/E -4.2x QuantScore34/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
32/100 |
50/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 0/100 | 67/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 50/100 | 27/100 |
Growth Revenue / earnings growth & margins | 43/100 | 11/100 | 10/100 |
Sentiment Analyst ratings, targets & revisions | 62/100 | 100/100 | 18/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.6x | -0.9x | -4.2x |
Forward P/E (next FY) | -1.8x | -0.9x | -13.9x |
EV / EBITDA (TTM) | -1.8x | -0.4x | -27.3x |
Price / Sales | 0.9x | — | 1.5x |
Price / Free Cash Flow | -2.6x | -1.2x | -21.4x |
PEG ratio | -0.07 | -0.05 | 0.11 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 1 / 9 | 2 / 9 |
Altman Z-Score | -5.82 (Distress) | -2.54 (Distress) | -3.71 (Distress) |
Total debt / equity | 1.43 | 0.02 | 0.53 |
Quick ratio | 3.5x | 8.0x | 1.6x |
Interest coverage | -12.3x | — | -7.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +8.0% | — | -5.0% |
Net income growth YoY | +4.2% | +3.3% | -40.7% |
Gross margin (TTM) | 77.1% | 0.0% | 44.3% |
Operating margin (FY) | -59.3% | — | -14.5% |
FCF margin (FY) | -36.4% | — | -23.7% |
5. Trailing price performancePrice change over period |
1M return | -3.7% | -18.4% | +900.0% |
3M return | +56.4% | +8.1% | +1204.1% |
6M return | +44.1% | -9.4% | +2011.4% |
Year to date | -17.2% | -28.2% | +159.1% |
1Y return | +11.6% | -16.4% | +2273.7% |
3Y return | -79.3% | -68.1% | +193.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-8.79 -580.6% premium | $0.9552 -44.8% premium | $86.61 +268.5% upside |
Wall Street consensus target | $10.00 +446.4% · range $2.50–$20.00 | $21.83 +1161.8% · range $17.00–$30.00 | $22.65 -3.6% · range $21.80–$23.50 |
Consensus stance | 44% Buy44% Hold11% Sell | 90% Buy10% Hold0% Sell | 44% Buy50% Hold6% Sell |